Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: Induction of tolerance and prevention of cardiac allograft vasculopathy

Circulation

Volumn 110, Issue 12, 2004, Pages 1650-1657

  Yamaura, Kazuhiro ^a   Ito, Ken Ichi ^a   Tsukioka, Katsuaki ^a   Wada, Yuko ^a   Makiuchi, Akiko ^a   Sakaguchi, Masayuki ^a   Akashima, Tomohiro ^a   Fujimori, Minoru ^a   Sawa, Yoshiki ^b   Morishita, Ryuichi ^b   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Suzuki, Jun Ichi ^c   Amano, Jun ^a   Isobe, Mitsuaki ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Growth substances; Immune system; Pathology; Rejection; Transplantation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; MESSENGER RNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT REJECTION; ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CELL INFILTRATION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GRAFT FAILURE; GRAFT SURVIVAL; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CHRONIC DISEASE; DRUG EVALUATION; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS; VASCULITIS;

EID: 20844441781     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000143052.45956.71     Document Type: Article

References (26)

1. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Heart Lung Transplant. 2001;20:805-815.
2. Waller J, Brook NR, Nicholson ML. Cardiac allograft vasculopathy: current concepts and treatment. Transplant Int. 2003;16:367-375.
3. VanBuskirk AM, Pidwell DJ, Adams PW, et al. Transplantation immunology. JAMA. 1997;278:1993-1999.
4. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342: 440-443.
5. Nakamura T, Mizuno S, Matsumoto K, et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest. 2000;106:1511-1519.
6. Ueda H, Nakamura T, Matsumoto K, et al. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res. 2001;51:41-50.
7. Hayashi K, Nakamura S, Morishita R, et al. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther. 2000;7:1664-1671.
8. Sakamaki Y, Matsumoto K, Mizuno S, et al. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol. 2002;26:525-533.
9. Gao X, Mae H, Ayabe N, et al. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int. 2002;62:1238-1248.
10. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5:226-230.
11. Mizuno S, Kurosawa T, Matsumoto K, et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest. 1998;101:1827-1834.
12. Taniyama Y, Morishita R, Aoki M, et al. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension. 2002;40:47-53.
13. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16:343-350.
14. Xia D, Sanders A, Shah M, et al. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation. 2001;72:907-914.
15. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med. 1991;174:493-496.
16. Saiura A, Mataki C, Murakami T, et al. A comparison of gene expression in murine cardiac allografts and isografts by means of DNA microarray analysis. Transplantation. 2001;72:320-329.
17. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199-210.
18. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 2001;166: 3789-3796.
19. + regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J Exp Med. 2001;194: 629-644.
20. Nagano H, Mitchell RN, Taylor MK, et al. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 1997;100:550-557.
21. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207-211.
22. Kuro-o M, Nagai R, Nakahara K, et al. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem. 1991;266: 3768-3773.
23. Azuma H, Takahara S, Matsumoto K, et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol. 2001;12:1280-1292.
24. Tashiro H, Fudaba Y, Itoh H, et al. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats. Transplantation. 2003;76:761-765.
25. Sullivan TJ, Letterio JJ, van Elsas A, et al. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc Natl Acad Sci U S A. 2001;98:2587-2592.
26. Raju GP, Belland SE, Eisen HJ. Prolongation of cardiac allograft survival with transforming growth factor-β1 in rats. Transplantation. 1994;58: 392-396.